Clinical trial
Primary Prevention of MACE With Standard and Intensive Statin Treatment in Hypercholesterolemia Patients With Concomitant Diabetes and Hypertension
NCT01173939 is registered in ClinicalTrials.gov with Positive Trial Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primary Prevention of MACE With Standard and Intensive Statin Treatment in Hypercholesterolemia Patients With Concomitant Diabetes and Hypertension
- Lead sponsor
- Positive Trial Group
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- Not reported
- Enrollment
- 10,000 (estimated)
- Sites
- 317
Conditions
As the registry lists them; a condition with its own page is linked.
hypercholesterolemia, hypertension, type 2 diabetes